The study, led by Felipe Padilla-Vaca and Bernardo Franco, was purely computational and hypothesis-driven, but its scope was ambitious. The researchers compared the complete Rab GTPase repertoires of E. histolytica, humans, and the free-living social amoeba Dictyostelium discoideum, which encodes twenty-eight Rab proteins that share more than forty percent sequence identity with their human or yeast counterparts. Using AlphaFold3 to predict the three-dimensional structures of every Rab protein bound to its GTP ligand, the team asked a deceptively simple question: if the parasite has so many Rab genes, are they redundant copies doing the same job, or are they subtly different machines doing subtly different things? The answer, it turns out, is neither straightforward nor what anyone expected.

At first glance, the sequences told a familiar story. The vast majority of the parasite’s Rab GTPases exhibit the conserved sequence motifs and the characteristic fold that define the family across all of eukaryotic life. But two proteins stood out immediately: EhRabX3 and EhRabX14, members of the so-called X isoforms — thirty-nine Rab genes unique to Entamoeba species with no clear homologs elsewhere. Both carry long N-terminal or C-terminal extensions that bear no resemblance to any known domain. When the researchers ran these extensions through BLAST, the only hits were other Entamoeba proteins. Whatever these appendages do, they evolved within this parasite lineage alone, and no database offers a hint about their function.

The real surprise came when the team looked past the sequences and into the structures. Rab GTPases work by binding GTP, hydrolyzing it to GDP, and using that cycle to recruit the machinery that docks vesicles at their correct destinations. The residues that grip the nucleotide — the so-called G1, G2, G4, and G5 motifs — are among the most conserved in biology. Or so everyone thought. When the researchers mapped the GTP-interacting residues onto their AlphaFold3 models, they found that the phosphate-binding motif is distinctly different across the parasite’s Rab family. In some groups, the involvement of the G5 motif in stabilizing the nucleotide base is diminished. In others, only two residues participate in the G1 and G4 interactions — a configuration so rare among Rab GTPases that the researchers describe it as non-canonical. The implication is profound: even though the overall fold is conserved, the way GTP binding is physically accomplished may vary substantially from one Rab protein to the next, meaning that in vivo regulation of these switches could be far more diverse than sequence conservation alone would suggest.

To test whether these differences were real or artifacts of prediction, the team cross-checked their models against experimentally determined crystal structures. Human Rab1A, Rab5A, and Rab11A have been crystallized in both GTP- and GDP-bound states, and the AlphaFold3 models reproduced those structures with root-mean-square deviations as low as 0.83 angstroms. For Rab1A and Rab11A, the parasite’s predicted proteins interact with GTP using the same residues and the same physicochemical contacts as their human counterparts. But Rab5 told a different story. In the human protein, a phenylalanine residue stabilizes the nitrogenous base of the nucleotide; in the E. histolytica version, a lysine residue does the job, assisted by an alanine. It is a small change with potentially large consequences for catalysis, because the identity of the residues surrounding the nucleotide determines how quickly GTP is hydrolyzed — and hydrolysis rate is the clock that sets the tempo of vesicle trafficking.

The team then turned to a novel structural phylogenetic method called FoldTree, developed by Moi and colleagues in 2025, which builds evolutionary trees from protein three-dimensional shapes rather than amino acid sequences. Traditional sequence-based phylogenies of Rab GTPases have long been confounded by the highly variable N-terminal regions, which can cluster similar-looking proteins that are not actually evolutionarily related. FoldTree, which uses a local structural alphabet to align proteins in an all-versus-all comparison, sidesteps this problem. When the researchers applied it to the full dataset, keeping the low-confidence N-terminal regions, the results matched the sequence-based trees. But when those regions were removed, the picture changed dramatically: several E. histolytica X isoforms, including RabX17, RabX21, and RabX29, emerged as more divergent than previously appreciated, while others, such as RabX14, clustered with human Rab18 and Rab23, suggesting functional relationships that sequence analysis alone had missed.

Perhaps the most consequential finding concerns drug discovery. Rab GTPases have long been considered attractive targets for antiparasitic therapy precisely because parasites rely so heavily on vesicular trafficking to secrete virulence factors and evade the immune system. E. histolytica releases extracellular vesicles ranging from fifty to six hundred nanometers in diameter that suppress neutrophil respiratory burst and delay the formation of neutrophil extracellular traps, and Rab7A and Rab32 have been identified among the proteins carried within those vesicles. But the new structural data suggest that targeting these enzymes pharmacologically may be harder than hoped. Because the GTP-binding residues are so highly conserved between parasite and host, a drug designed to disrupt nucleotide binding in the parasite would likely interfere with the same residues in human cells. The researchers conclude that Rab GTPases may be less than ideal drug targets — a sobering assessment for a family of proteins that has been on the wish list of antiparasitic drug developers for years.

So why does a single-celled anaerobic parasite need more than ninety Rab GTPases when a human gets by with sixty-three? The structural and phylogenetic evidence points to a strategy of fine-tuning rather than redundancy. Multiple Rab proteins appear to regulate overlapping steps in vesicle formation, cargo loading, and delivery, allowing the parasite to adjust protein sorting with a precision that compensates for its lack of complex multicellular organization. The team suggests that the X isoforms may have arisen from gene duplications that occurred early in the Entamoeba lineage and then diverged under the pressures of host-parasite interaction, acquiring new regulatory properties while retaining their catalytic cores. Some, like RabX3, may even function as pseudoenzymes — scaffolds that organize trafficking complexes without hydrolyzing GTP themselves — while others, like RabX12, carry predicted transmembrane domains that could anchor them to vesicle or cell membranes in ways no canonical Rab can.

The study is explicitly computational, and the authors are careful to note that every prediction requires experimental validation. Genetic tools for E. histolytica remain limited: gene silencing works reliably only in a laboratory strain that lacks amoebapore A, a key virulence factor, which complicates any attempt to connect Rab function to pathogenesis. The researchers call for high-throughput gene disruption methods that could test multiple Rab mutants simultaneously, and they argue that their structural framework provides exactly the kind of testable hypotheses such experiments will need. Whether the expanded Rab repertoire of E. histolytica represents an evolutionary relic, a specialized adaptation to parasitic life, or something else entirely, the answer will require years of bench work. But the message from this study is clear: even in the most conserved protein families, evolution finds room for surprise, and the molecular switches that direct traffic inside one of humanity’s oldest parasitic enemies are far more varied than anyone imagined.

Subject of Research: Structural diversity and regulatory evolution of the expanded Rab GTPase family in the parasitic protist Entamoeba histolytica

Article Title: Deciphering the structural diversity and regulatory layers of expanded Rab GTPases families in the parasitic protist Entamoeba histolytica

Article References: Vargas-Maya, N. I., López-Pérez, J. I., Martínez-Álvarez, J. A., Medina-Nieto, A. L., Andrade-Guillén, S. Y., Ramírez-Montiel, F. B., Rangel-Serrano, Á., Páramo-Pérez, I., de la Mora, J., Mendoza-Macías, C. L., Padilla-Vaca, F., & Franco, B. (2026). Deciphering the structural diversity and regulatory layers of expanded Rab GTPases families in the parasitic protist Entamoeba histolytica. Frontiers in Chemical Biology, 5, Article 1931419. https://doi.org/10.3389/fchbi.2026.1931419

Image Credits: AI Generated

DOI: 10.3389/fchbi.2026.1931419

Keywords: Entamoeba histolytica, Rab GTPases, AlphaFold3, vesicular trafficking, structural phylogenetics, GTP binding, parasitic protist, Dictyostelium discoideum, extracellular vesicles, drug targets, molecular evolution, protein structure prediction